Physician profile
Jason A Smith
NPI 1710140314
$537.60
in general payments reported to CMS, 2019-2025
8 companies · $131 in 2025
The $131 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.42 · 2020: $132 · 2021: $15.52 · 2022: $74.77 · 2023: $34.40 · 2024: $83.67 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $248.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $290.73 | 2020-2025 | Evenity, Prolia, Prolia |
| Hydrocision, INC. | $83.67 | 2024 | Tenjet |
| Bioventus LLC | $48.75 | 2019-2025 | Gelsyn-3 |
| Radius Health, INC. | $47.02 | 2021-2025 | Tymlos |
| Sun Pharmaceutical Industries INC. | $20.40 | 2019 | |
| Vericel Corporation | $18.32 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $15.88 | 2025 | |
| Sanofi-Aventis U.S. LLC | $12.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.